{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:50Z","timestamp":1791474710243,"version":"4.3.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pediatric immune thrombocytopenia (ITP) usually has a favorable prognosis, although some children progress to chronic disease (&gt;12\u00a0mo). A 2014 meta-analysis by Heitink-Poll\u00e9 and colleagues identified important prognostic markers that informed tools such as the Nordic prediction score. Given advances in diagnosis over the past decade, updated evidence focusing on simple bedside predictors is needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate post-2014 evidence on baseline clinical and laboratory predictors of chronic pediatric ITP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Following PRISMA 2020 guidelines, PubMed and Embase were searched for observational studies. Of 876 identified records, 26 studies were included in the systematic review and 24 in the meta-analysis (N&gt;4000). Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Older age at diagnosis (OR 2.25) and insidious onset (OR 6.20) remained the strongest predictors of chronicity. Absence of preceding infection (OR 2.66) and female sex (OR 1.43) were also associated with chronic disease. Higher baseline platelet count (OR 2.14) demonstrated a similar trend, though this finding is limited by extreme heterogeneity (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      =78%) across studies. In a single study, mild bleeding predicted chronicity compared with moderate\/severe bleeding (OR 2.86).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings validate the Nordic Score framework and support risk stratification using simple, reproducible clinical parameters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003305","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:37Z","timestamp":1791471637000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Revisiting Pediatric ITP Prognosis: A Systematic Review and Meta-analysis of Simple Clinical and Laboratory Predictors of Chronic Disease"],"prefix":"10.1097","author":[{"given":"Ahmad Sameer","family":"Ashi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, King Abdulaziz Hospital & Oncology Center, Ministry of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5616-1371","authenticated-orcid":false,"given":"Omar Ahmed","family":"Alshaikhi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, King Abdulaziz Hospital & Oncology Center, Ministry of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5895-1739","authenticated-orcid":false,"given":"Elaf Yahia","family":"Alnasser","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, King Abdulaziz Hospital & Oncology Center, Ministry of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"R2-20261008","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2014-04-570127","article-title":"Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis","volume":"124","author":"Heitink-Poll\u00e9","year":"2014","journal-title":"Blood"},{"key":"R3-20261008","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jth.15125","article-title":"A clinical prediction score for transient versus persistent childhood immune thrombocytopenia","volume":"19","author":"Schmidt","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R4-20261008","first-page":"1","article-title":"Risk of bias evaluation of cross-sectional studies: adaptation of the Newcastle-Ottawa scale","volume":"60","author":"Carra","year":"2025","journal-title":"J Periodontal Res"},{"key":"R5-20261008","first-page":"1","article-title":"The prognostic value of the systemic immune-inflammatory index and the systemic inflammation response index in pediatric immune thrombocytopenia","volume":"73","author":"Elmeazawy","year":"2025","journal-title":"Egypt Pediatr Assoc Gaz"},{"key":"R6-20261008","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/apa.70090","article-title":"Immune thrombocytopenia in Finnish children and adolescents: a population-based cohort study","volume":"114","author":"Kulmala","year":"2025","journal-title":"Acta Paediatr"},{"key":"R7-20261008","first-page":"90","article-title":"Evaluation of children with immune thrombocytopenia","volume":"56","author":"Turkozkan Ibis","year":"2025","journal-title":"Zeynep Kamil Med J"},{"key":"R8-20261008","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s13312-024-3201-5","article-title":"Clinical outcome and its predictors in children with newly diagnosed immune thrombocytopenia","volume":"61","author":"Singaravadivelu","year":"2024","journal-title":"Indian Pediatr"},{"key":"R9-20261008","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/diagnostics13030341","article-title":"Predictors of remission in severe childhood immune thrombocytopenia","volume":"13","author":"Cheng","year":"2023","journal-title":"Diagnostics"},{"key":"R10-20261008","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4274\/jpr.galenos.2023.06992","article-title":"Assessment of clinical and laboratory predictors for chronic childhood immune thrombocytopenia","volume":"10","author":"Alpdo\u011fan","year":"2023","journal-title":"J Pediatr Res"},{"key":"R11-20261008","doi-asserted-by":"crossref","first-page":"101396","DOI":"10.1016\/j.rpth.2023.101396","article-title":"PB0261 prediction of favorable outcome and quality of life of children diagnosed with immune thrombocytopenia","volume":"7","author":"Sirachainan","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"R12-20261008","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/children10060911","article-title":"Predictor factors for chronicity in immune thrombocytopenic purpura in children","volume":"10","author":"Rosu","year":"2023","journal-title":"Children"},{"key":"R13-20261008","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1097\/MPH.0000000000002508","article-title":"Re-evaluate the prognostic value of absolute lymphocyte count in pediatric immune thrombocytopenia","volume":"45","author":"Yang","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"R14-20261008","doi-asserted-by":"crossref","first-page":"123","DOI":"10.18678\/dtfd.1203898","article-title":"Evaluation of pediatric immune thrombocytopenia (ITP) cases and risk factors for chronic ITP - single center experience","volume":"25","author":"Erdo\u011fan","year":"2023","journal-title":"D\u00fczce T\u0131p Fak\u00fcltesi Dergisi"},{"key":"R15-20261008","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MBC.0000000000001146","article-title":"Evaluation of paediatric immune thrombocytopenia patients with clinical and laboratory findings: emphasizing the role of monocytosis","volume":"33","author":"Akyol","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R16-20261008","first-page":"100","article-title":"Predictors of remission in childhood immune thrombocytopenia","volume":"27","author":"Fly","year":"2022","journal-title":"HK J Paediatr (new series)"},{"key":"R17-20261008","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00431-021-03990-8","article-title":"Variables related to chronic immune thrombocytopenia: experience from a single center and comparison to a meta-analysis","volume":"180","author":"Fern\u00e1ndez-Plaza","year":"2021","journal-title":"Eur J Pediatr"},{"key":"R18-20261008","doi-asserted-by":"crossref","first-page":"26","DOI":"10.24287\/1726-1708-2021-20-3-26-30","article-title":"Prognostic evaluation of immune thrombocytopenia outcomes in Egyptian children: a retrospective single-center experience","volume":"20","author":"Diab","year":"2021","journal-title":"Pediatr Hematol Oncol Immunopathol"},{"issue":"suppl 1","key":"R19-20261008","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1182\/blood-2021-154344","article-title":"Evaluating clinical outcomes and potential prognostic factors among 308 children and adolescents with immune thrombocytopenia (ITP): An 11-year retrospective cohort study","volume":"138","author":"Zeng","year":"2021","journal-title":"Blood"},{"key":"R20-20261008","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00277-020-04257-2","article-title":"Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center","volume":"99","author":"Jaime-P\u00e9rez","year":"2020","journal-title":"Ann Hematol"},{"key":"R21-20261008","first-page":"535","article-title":"Clinical and laboratory factors affecting chronicity in children diagnosed with immune thrombocytopenia","volume":"13","author":"Ay","year":"2020","journal-title":"Pamukkale Med J"},{"key":"R22-20261008","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MPH.0000000000001167","article-title":"Cutaneous hemorrhage types as supportive factors for predicting chronic immune thrombocytopenia in children","volume":"40","author":"Kalfon","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"R23-20261008","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.pedneo.2018.10.002","article-title":"Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity","volume":"60","author":"G\u00fcng\u00f6r","year":"2019","journal-title":"Pediatr Neonatol"},{"key":"R24-20261008","first-page":"1","article-title":"Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants","volume":"65","author":"Bennett","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R25-20261008","doi-asserted-by":"crossref","first-page":"7878605","DOI":"10.1155\/2017\/7878605","article-title":"Prognostic factors for immune thrombocytopenia outcome in Greek children: a retrospective single-centered analysis","volume":"2017","author":"Makis","year":"2017","journal-title":"Adv Hematol"},{"key":"R26-20261008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12288-016-0664-0","article-title":"Initial lymphocyte count as prognostic indicator for childhood immune thrombocytopenia","volume":"33","author":"Akbayram","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R27-20261008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pbc.26178","article-title":"Predictive factors for resolution of childhood immune thrombocytopenia: experience from a single tertiary center in Thailand","volume":"64","author":"Chotsampancharoen","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R28-20261008","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3345\/kjp.2016.59.8.335","article-title":"Clinical course and prognostic factors of childhood immune thrombocytopenia: single center experience of 10 years","volume":"59","author":"Jung","year":"2016","journal-title":"Korean J Pediatr"},{"key":"R29-20261008","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/pbc.25732","article-title":"Pediatric immune thrombocytopenia in Lebanon: treatment and predictors of outcome","volume":"63","author":"Inati","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R30-20261008","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7754\/Clin.Lab.2020.200715","article-title":"Can we predict the clinical course of immune thrombocytopenia in children by the mean platelet volume? A preliminary study","volume":"67","author":"Lee","year":"2021","journal-title":"Clin Lab"},{"key":"R31-20261008","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jpeds.2013.06.018","article-title":"Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months","volume":"163","author":"Revel-Vilk","year":"2013","journal-title":"J Pediatr"},{"key":"R32-20261008","doi-asserted-by":"crossref","first-page":"870064","DOI":"10.3389\/fped.2022.870064","article-title":"The use of clinical scores in the management of immune thrombocytopenic purpura in children","volume":"10","author":"Ro\u015fu","year":"2022","journal-title":"Front Pediatr"},{"key":"R33-20261008","doi-asserted-by":"crossref","first-page":"e960","DOI":"10.1097\/HS9.0000000000000960","article-title":"Prediction of the clinical course of immune thrombocytopenia in children by platelet kinetics","volume":"7","author":"Lejeune","year":"2023","journal-title":"Hemasphere"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:41Z","timestamp":1791471641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003305","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"2026-05-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}